Sponsor
Managing Multiple Myeloma: From MGUS to Modern Immunotherapy
Multiple Myeloma (MM) is a hematologic malignancy arising from abnormal clonal proliferation of plasma cells in the bone marrow. These malignant cells produce monoclonal immunoglobulin (M-protein), leading to end-organ damage, including bone destruction, renal impairment, anemia, and hypercalcemia. While MM remains incurable, recent therapeutic advances have significantly prolonged survival and...
0 Reacties 0 aandelen 68 Views 0 voorbeeld
Sponsor
Sponsor
Sponsor